RRM1 and non-small cell lung carcinoma: RRM1 staining correlated to general drug sensitivity of primary cells (Figure 5A), comparable findings have been seen in non-small cell lung cancer patients treated with cisplatin and vinorelbine, where immunohistochemical evaluation of RRM1 predicted drug effect [42].